Please send the following information, abstract, NIH Biosketch and other support information in one file titled with your last name to Natalie Lewis-Ross.

Demographic
First name, Last name, Degree(s), Academic title, 2nd Academic title, Administrative title, Department affiliation, Local address, Local phone #, Local fax #, Email address, Year of membership.

Programmatic
Two types of programs are operative at the NYUCI: CCSG Research Programs and Disease Management Groups. The Research Programs currently form the basic discovery units of the Institute and the CCSG. They meet the full NCI guidelines including benchmarks for competitively funded research and highly interactive, multi-investigator projects. Disease Management Groups focus more on the clinical research interests of the full range of human cancers even if they are not a current, major area of NYUCI laboratory research. Disease Management Groups are critical to the success of the NYUCI. The multidisciplinary team meets to plan, prioritize and successfully implement disease or organ-specific protocols as well as developing systems for banking human samples. Under optimal circumstances NYU investigator-initiated research protocols are expected to be linked to one or more of the Institute's CCSG Research Programs. Disease Groups may meet as more classic multidisciplinary “Tumor Boards” with an additional focus on translational research. Active involvement of more basic scientists is encouraged since the challenges of diagnosis and effective therapy can be appreciated by these investigators. Some Disease Groups are likely to become "Developing" CCSG Research Programs if it is clear that they link substantial basic, translational and clinical research.

Please indicate which Research Program and/or Disease Management Groups you would like to join. Members may be linked to two Programs or Groups but active participation will be expected in each program.

CCSG Research Programs

• Environmental and Molecular Carcinogenesis - Max Costa, Ph.D.
• Stem Cell Biology - TBN
• Growth Control - Michele Pagano M.D.
• Cancer Immunology - David Roth, M.D., Ph.D., Michael Dustin, Ph.D.
• Breast - Sylvia Formenti M.D., Robert Schneider M.D., Ph.D.
• GU - Anna Ferrari, M.D., Samir Taneja, M.D.
• Melanoma - Nina Bhardwaj, M.D., Ph.D., Iman Isman, M.D., Anna Pavlick, D.O.

• Breast - Sylvia Fomenti M.D., Robert Schneider M.D., Ph.D.
• Neuro-Oncology - Jeffrey Allen M.D., John Golfinos M.D., Michael Gruber, M.D.
• Childhood Cancer - Sharon Gardner, M.D., Elizabeth Raetz, M.D.
• Cutaneous Malignancies - Nina Bhardwaj, M.D., Anna Pavlick M.D.
• Hematological Malignancies - Bruce Raphael, M.D. and TBN
• Lung/Upper Aerodigestive - Abe Chachoa, M.D., William Rom, M.D.
• GYN Oncology - John Curtin M.D., David Fishman M.D.
• GU - Samir Taneja M.D., Anna Ferrari M.D.
• GI - Howard Hochster M.D., Eliot Newman M.D.
• Sarcoma - James Wittig, M.D. and TBN

• Completed application
• Abstract of your research interests (200 words)
• Key Words describing research (Up to 5)
• NIH Biosketch
• Grant information (if you are the PI), title, granting agency, grant number, dates of entire project, direct and total costs for both the current year and for the entire project. This is identical to the NIH Other Support information. If none, please state so.